SPOTLIGHT: Glaxo faces investor uprising


The natives are restless and are ready for a butchering. Inspired by lackluster stock performance, GlaxoSmithKline's institutional shareholders are demanding big changes--perhaps even a break-up of the company--according to London newspapers. Report